March 19, 2024

Risk factors associated with high-dose methotrexate induced toxicities

Key Points

Key points are not available for this paper at this time.

Abstract

High-dose methotrexate (HDMTX) therapy poses challenges in various neoplasms due to individualized pharmacokinetics and associated adverse effects. Our purpose is to identify early risk factors associated with HDMTX-induced toxicities, paving the way for personalized treatment.

Bookmark

Cite This Study

Li et al. (Tue,) studied this question.

synapsesocial.com/papers/68e73502b6db6435876ae8d8 https://doi.org/https://doi.org/10.1080/17425255.2024.2332366

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Effect of Methotrexate/Vitamin B <sub>12</sub> on DNA Methylation as a Potential Factor in Leukemia Treatment-Related Neurotoxicity2017 · 31 citations
2Antioxidant and anti-inflammatory potential of spirulina and thymoquinone mitigate the methotrexate-induced neurotoxicity2023 · 28 citations
3How to rescue high-dose methotrexate induced nephrotoxicity and literature review about hemodiafiltration?2020 · 8 citations
4Methotrexate, rheumatoid arthritis and infection risk--what is the evidence?2009 · 127 citations
5Deregulation of the CXCL12/CXCR4 axis in methotrexate chemotherapy–induced damage and recovery of the bone marrow microenvironment2012 · 26 citations

Bookmark